Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Manulife Financial | MFC | Jun 27, 2024 | 26.50 | +2.36 |
Maquia Capital Acquisition A | MAQC | Jun 27, 2024 | 11.26 | +0.54 |
Marathon Digital | MARA | Jun 27, 2024 | 19.66 | +1.50 |
Marathon Oil | MRO | Jun 27, 2024 | 28.58 | +0.32 |
Marathon Petroleum | MPC | Jun 27, 2024 | 172.91 | -0.80 |
Maravai LifeSciences A | MRVI | Jun 27, 2024 | 7.08 | +2.02 |
Marblegate Acquisition A | GATE | Jun 27, 2024 | 10.85 | 0.00 |
Marchex B | MCHX | Jun 27, 2024 | 1.53 | +2.00 |
Marcus | MCS | Jun 27, 2024 | 11.15 | -1.33 |
Marcus & Millichap | MMI | Jun 27, 2024 | 31.42 | +1.65 |
Marex Group | MRX | Jun 27, 2024 | 19.50 | 0.00 |
MariaDB | MRDB | Jun 27, 2024 | 0.54 | +1.70 |
Marin Software | MRIN | Jun 27, 2024 | 2.36 | +3.96 |
Marine Petroleum Trust U | MARPS | Jun 27, 2024 | 3.94 | +0.90 |
Marine Products | MPX | Jun 27, 2024 | 9.93 | -1.10 |
MarineMax | HZO | Jun 27, 2024 | 32.13 | -2.01 |
Marinus Pharmaceuticals | MRNS | Jun 27, 2024 | 1.23 | -2.38 |
Maris-Tech | MTEK | Jun 27, 2024 | 1.33 | +6.26 |
Markel | MKL | Jun 27, 2024 | 1 579.11 | +0.61 |
Marker Therapeutics | MRKR | Jun 27, 2024 | 4.83 | +1.90 |
Market Vectors Bdc Income ETF | BIZD | Jun 27, 2024 | 17.14 | +0.65 |
Market Vectors Investment Grade | FLTR | Jun 27, 2024 | 25.49 | 0.00 |
Market Vectors Israel ETF | ISRA | Jun 27, 2024 | 35.77 | +0.94 |
Market Vectors Preferred Securi | PFXF | Jun 27, 2024 | 17.30 | -0.17 |
MarketAxess | MKTX | Jun 27, 2024 | 199.68 | +1.83 |
MarketWise A | MKTW | Jun 27, 2024 | 1.15 | +1.77 |
Markforged | MKFG | Jun 27, 2024 | 0.41 | +0.10 |
Marpai A | MRAI | Jun 27, 2024 | 1.94 | 0.00 |
Marqeta A | MQ | Jun 27, 2024 | 5.39 | +0.37 |
Marriott International A | MAR | Jun 27, 2024 | 242.25 | +0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.